Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Agile Therapeutics Inc. AGRX

Alternate Symbol(s):  AGXRW

Agile Therapeutics Inc is a women's healthcare company to fulfill the unmet health needs of women. Its product candidates are designed to provide women with contraceptive options. The firm's initial product, Twirla, (levonorgestrel and ethinyl estradiol) transdermal system is a non-daily prescription contraceptive. Twirla is based on proprietary transdermal patch technology, called Skinfusion, which is designed to allow drug delivery through the skin.


Recent & Breaking News (NDAQ:AGRX)

Agile Therapeutics Reports Additional Phase 3 SECURE Study Results Relating to Twirla® at ACOG 2017

GlobeNewswire May 6, 2017

Agile Therapeutics to Present Additional Phase 3 Data at the 2017 Annual Clinical and Scientific Meeting of the American Congress of Obstetricians and Gynecologists

GlobeNewswire May 3, 2017

Agile Therapeutics Announces Presentation of SECURE Phase 3 Data at the 2017 Congress on Women’s Health

GlobeNewswire April 27, 2017

Agile Therapeutics Announces Results of its Pre-Submission Meeting with FDA

GlobeNewswire April 11, 2017

Generic Drugs Stocks on Investors' Radar -- Diplomat Pharma, Momenta Pharma, Agile Therapeutics, and Sophiris Bio

PR Newswire April 7, 2017

15 Biggest Mid-Day Losers For Monday

Benzinga.com  March 20, 2017

15 Biggest Mid-Day Gainers For Friday

Benzinga.com  March 17, 2017

Agile Therapeutics Announces a Poster Presentation of its SECURE Phase 3 Study at the Contraceptive Technology 2017 Conference

GlobeNewswire March 16, 2017

Agile Therapeutics Reports Fourth Quarter and Full Year 2016 Financial Results

GlobeNewswire March 8, 2017

DEADLINE ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Agile Therapeutics, Inc. (AGRX) & Lead Plaintiff Deadline - March 7, 2017

GlobeNewswire March 6, 2017

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Agile Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadline – AGRX

GlobeNewswire March 3, 2017

UPCOMING DEADLINE: Levi & Korsinsky, LLP Reminds Shareholders of Agile Therapeutics, Inc. of Commencement of a Class Action Lawsuit and a Lead Plaintiff Deadline of March 7, 2017

Business Wire March 3, 2017

EQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Agile Therapeutics, Inc. - AGRX

PR Newswire March 2, 2017

How These Generic Drugs Stocks are Faring? -- Diplomat Pharmacy, Momenta Pharma, Agile Therapeutics, and Sophiris Bio

PR Newswire March 2, 2017

Agile Therapeutics to Present at 29th Annual ROTH Conference

GlobeNewswire March 1, 2017

DEADLINE ALERT: Brower Piven Reminds Investors Of The March 7, 2017 Deadline In Class Action Lawsuit And Encourages Investors With Losses In Excess of $100,000 From Investment In Agile Therapeutics, Inc. To Contact The Firm

Business Wire February 27, 2017

AGRX INVESTOR ALERT: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving Agile Therapeutics, Inc. and a Lead Plaintiff Deadline of March 7, 2017

Business Wire February 27, 2017

Investor Alert: GPM Reminds Investors of the March 7 Deadline in the Class Action Lawsuit Against Agile Therapeutics, Inc.

Business Wire February 24, 2017

AGRX SHAREHOLDER ALERT: The Law Offices of Vincent Wong Reminds Investors of Commencement of a Class Action Involving Agile Therapeutics, Inc. and a Lead Plaintiff Deadline of March 7, 2017

PR Newswire February 22, 2017

INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Agile Therapeutics, Inc. of Commencement of a Class Action Lawsuit and a Lead Plaintiff Deadline of March 7, 2017 – AGRX

Business Wire February 17, 2017